- In February 2024, Varian Medical Systems, Inc. obtained FDA 510(k) clearance for its TrueBeam and Edge radiotherapy systems, now incorporating the HyperSight imaging solution. This approval enables the company to enhance imaging capabilities within the radiotherapy treatment room, significantly improving the precision of cancer treatments. By integrating this advanced imaging technology, Varian aims to strengthen its market presence and offer superior solutions to healthcare providers in oncology
- In May 2023, STERIS announced the establishment of a new electron beam processing facility in Biassono, Italy, underscoring its commitment to enhancing medical device manufacturing. This facility will expand the company’s electron beam processing capacity, allowing for improved sterilization and treatment of medical products. By investing in this state-of-the-art facility, STERIS aims to strengthen its position in the market and better meet the growing demand for high-quality medical devices
- In October 2023, Washington State University announced the installation of a cutting-edge linear accelerator, marking a significant advancement in cancer treatment technology. This new equipment will provide enhanced radiation therapy and essential treatments specifically for animal cancer patients at the Veterinary Teaching Hospital. This development underscores the institution's commitment to improving veterinary care and expanding treatment options for pets facing cancer
- In October 2022, the Raja Ramanna Centre for Advanced Technology revealed a partnership with a Mumbai-based company to incubate an electron linear accelerator (Linac) designed for sterilizing medical devices. This collaboration aims to develop advanced technology that enhances the safety and efficacy of medical sterilization processes. By focusing on innovative solutions, the initiative highlights the commitment to improving healthcare standards and ensuring the availability of safe medical products
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Low-ENERGY MACHINE and High-Energy Machine), End User (Hospital, Ambulatory Care Centres, Clinics, Academic, and Research Centres) – Industry Trends and Forecast to 2031
.
The Global Electron Beam Linear Accelerator Market size was valued at USD 737.46 USD Million in 2023.
The Global Electron Beam Linear Accelerator Market is projected to grow at a CAGR of 4.21% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.